Graves' disease, known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid.
FactSnippet No. 741,403 |
Graves' disease, known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid.
FactSnippet No. 741,403 |
Exact cause of the Graves' disease is unclear; however, it is believed to involve a combination of genetic and environmental factors.
FactSnippet No. 741,404 |
Genetic predisposition for Graves' disease is seen, with some people more prone to develop TSH receptor activating antibodies due to a genetic cause.
FactSnippet No. 741,405 |
Graves' disease is an autoimmune disorder, in which the body produces antibodies that are specific to a self-protein: the receptor for thyroid-stimulating hormone.
FactSnippet No. 741,406 |
Hyperthyroidism in Graves' disease is confirmed, as with any other cause of hyperthyroidism, by measuring elevated blood levels of free T3 and T4.
FactSnippet No. 741,407 |
Goiter in Graves' disease is often not nodular, but thyroid nodules are common.
FactSnippet No. 741,408 |
Treatment of Graves' disease includes antithyroid drugs that reduce the production of thyroid hormone, radioiodine and thyroidectomy .
FactSnippet No. 741,409 |
Eyelid muscles can become tight with Graves' disease, making it impossible to close the eyes all the way.
FactSnippet No. 741,410 |
Graves' disease owes its name to the Irish doctor Robert James Graves, who described a case of goiter with exophthalmos in 1835.
FactSnippet No. 741,411 |
However, fair credit for the first description of Graves' disease goes to the 12th century Persian physician Sayyid Ismail al-Jurjani, who noted the association of goiter and exophthalmos in his Thesaurus of the Shah of Khwarazm, the major medical dictionary of its time.
FactSnippet No. 741,412 |